Global Implantable ports Market, By Product Type (Single Lumen, Duel Lumen), Material Type (Polyurethane, Polyethylene, Silicone, Others), Application (Chemotherapy, Blood Transfusion, Antibiotics, Intravenous Infusion of Blood Product, Pain Management, Others), End User (Hospitals, Clinics, Ambulatory Sugary Center, Dialysis Centers, Others) – Industry Trends and Forecast to 2029
Implantable Ports Market Analysis and Size
Over the last few years, there has been immense growth in chronic diseases. Additionally, with the transition from console toward mobile, participation in implantable ports has surged rapidly. In addition, it has been estimated that 15,270 kids and teenagers between the ages of 0 and 19 had cancer diagnoses in 2017, of which 1,790 lost their lives to the illness. Therefore, the market is estimated to grow rapidly over forecasted period.
Global implantable ports market was valued at USD 609.72 million in 2021 and is expected to reach USD 1079.36 million by 2029, registering a CAGR of 7.4% during the forecast period of 2022-2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team includes in-depth expert analysis, import/export analysis, pricing analysis, production consumption analysis, and consumer behavior.
Implantable Ports Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product Type (Single Lumen, Duel Lumen), Material Type (Polyurethane, Polyethylene, Silicone, Others), Application (Chemotherapy, Blood Transfusion, Antibiotics, Intravenous Infusion of Blood Product, Pain Management, Others), End User (Hospitals, Clinics, Ambulatory Sugary Center, Dialysis Centers, Others)
|
|
Countries Covered
|
U.S., Canada, Mexico, Brazil, Argentina, Rest of South America, Germany, France, Italy, U.K., Belgium, Spain, Russia, Turkey, Netherlands, Switzerland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, U.A.E, Saudi Arabia, Egypt, South Africa, Israel, Rest of Middle East and Africa
|
|
Market Players Covered
|
A.M.I GmBH (Austria) GlaxoSmithKline plc(U.K), Bausch Health Companies Inc., (Canada), Teligent (U.S.), Perrigo Company plc (U.S.), Allergan (Ireland), Biofrontera, AG (U.S.), Crown (U.S.), Akorn Operating Company LLC. (U.S.), Ingenus (U.S.), Vygon (U.S.), Merck & Co Inc., (U.S.), Bayer AG (Germany), Teleflex Inc (U.S.), Hisamitsu Pharmaceutical Co.,Inc. (Japan), B. Braun Melsungen AG (Germany), Glenmark Pharmaceuticals Limited, (India), Cipla Inc., (India), Crescita Therapeutics (Canada), AngioDynamics (U.S.) and Mylan N.V. (U.S.)
|
|
Market Opportunities
|
|
Market Definition
An implantable port is a small reservoir linked to a thin, soft silicone tube. It is typically placed in the arm or beneath the skin of the chest. The tube's other end is connected to the port, and its other end is inserted into a sizable vein located immediately above the person's heart. Subcutaneous ports, chest ports, and portacaths are further names for implantable ports. Chemotherapy, blood transfusions, and the infusion of antibiotics and other medications all employ implantable ports. Blood testing can also be performed through ports. These are very helpful for slowly injecting medication directly into a vein.
Implantable Ports Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:
Drivers
- High Prevalence of Chronic Diseases
As per the Cancer Treatment and Survivorship by 2026, there will be 20.3 million cancer survivors worldwide. It has been suggested that a practical catheter for long-term usage of chemotherapy and hydration administration in cancer patients is an implanted venous access port. The market for implantable ports is primarily being driven by an increase in the prevalence of chronic diseases like cancer, diabetes, and chronic obstructive pulmonary disease, a growth in product demand due to a low infection rate which is projected to create outstanding demand for the implantable ports during the forecasted period.
- Increased Usage of Implantable Ports
The utilization of the implantable port devices for medicine infusion has a number of benefits. Moreover, due to the fact that those ports are implanted for a longer period of time and can be utilized to provide specific medications that cannot be administered via the standard intravenous route. Implantable port devices also reduce infection risk by reducing the need for needle or catheter insertion. Implantable port devices aim to encourage patients to move around and engage in physical activity while receiving infusion treatments, such as chemotherapy for cancer.
The large cancer patient population and rise in number of cancer treatment centers will further propel the growth rate of implantable ports market. Additionally, the increase in health care expenditure along with the rapid urbanization will drive market value growth over the forecasted timeframe.
Opportunities
- Advancements and Favourable Scenario
Furthermore, the advances and innovations within the field further extend profitable opportunities to the market players in the forecast period of 2022 to 2029. Additionally, the favorable reimbursement scenario will further expand the future growth of the implantable ports market.
Restraints/Challenges
- Adverse Effects of Implantable ports
The main factors limiting the growth of the worldwide implanted port devices market are the negative effects related to implantable port devices, such as blocked lines and blood clots in port. factor will create hindrances for the growth of the implantable ports market.
- Availability of Substitutes
The availability of substitute products will prove to be a demerit for the implantable ports market. Therefore, this factor is anticipated to challenge the implantable ports market growth rate.
This implantable ports market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the implantable ports market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Implantable Ports Market Scope
The implantable ports market is segmented on the basis of product type, material type, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product Type
- Single Lumen
- Duel Lumen
Material Type
- Polyurethane
- Polyethylene
- Silicone
- Others
Application
- Chemotherapy
- Blood Transfusion
- Antibiotics
- Intravenous Infusion of Blood Product
- Pain Management
- Others
End User
- Hospitals
- Clinics
- Ambulatory Sugary Center
- Dialysis Centers
- Others
Implantable Ports Market Regional Analysis/Insights
The implantable ports market is analyzed and market size insights and trends are provided by country, product type, material type, application and end user as referenced above.
The countries covered in the implantable ports market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, Israel, Egypt, South Africa, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period of 2022-2029. The market growth over this region is attributed to the increasing applications within the region.
Asia-Pacific on the other hand, is estimated to show lucrative growth over the forecast period of 2022-2029, due to the increasing spending on research and development in the emerging economies in the region.
The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Implantable Ports Market Share Analysis
The implantable ports market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to implantable ports market.
Some of the major players operating in the implantable ports market are
- A.M.I GmBH (Austria)
- GlaxoSmithKline plc (U.K)
- Bausch Health Companies Inc., (Canada)
- Teligent (U.S.)
- Perrigo Company plc (U.S.)
- Allergan (Ireland)
- Biofrontera, AG (U.S.)
- Crown (U.S.)
- Akorn Operating Company LLC. (U.S.)
- Ingenus (U.S.)
- Vygon (U.S.)
- Merck & Co Inc., (U.S.)
- Bayer AG (Germany)
- Teleflex Inc (U.S.)
- Hisamitsu Pharmaceutical Co.,Inc. (Japan)
- B. Braun Melsungen AG (Germany)
- Glenmark Pharmaceuticals Limited (India)
- Cipla Inc., (India)
- Crescita Therapeutics (Canada)
- AngioDynamics (U.S.)
- Mylan N.V. (U.S.)
SKU-